Bioanalysis of Oligonucleotides

Bioanalysis of Oligonucleotides
Product Description

We quantify according to GLP nucleic acids in various biological matrices for you. We develop standardized and reproducible methods that will bring you through FDA/EMA registration. No matter which nucleic acids you develop as therapeutics, biomarkers or similar, we offer you the quantification of your nucleic acids and oligonucleotides in various biological matrices. We develop standardized and reproducible methods under GLP according to the latest guidelines for many substance groups: RNA, DNA, mRNA, RNA Therapeutics (AntagomiRs), small non-coding RNAs (siRNAs, miRNAs). We support you in many areas of your research. Benefit from our experience in active substance and biomarker development. We have specific oligonucleotide experience in active substance or biomarker search/development, preclinical studies, clinical trials (Phases 0-III) and bioequivalence/bioavailability studies. 

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPHI since
  • 100 - 249
    Employees
Company types
Contract Service
Specifications

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPHI since
  • 100 - 249
    Employees
Company types
Contract Service

More Products from Kymos Pharma Services, S.L. (22)

  • Pharmacokinetics of Therapeutic Proteins

    Product Pharmacokinetics of Therapeutic Proteins

    We are fully compliance with the EMA guideline on Clinical Investigation of the Pharmacokinetics of Therapeutic Proteins and other regulations and guidelines of the FDA. Our experience covers a wide range of different kind of large molecules: • Hormones • Biosimilars: protein...
  • PK Calculations & Statistics

    Product PK Calculations & Statistics

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes pk calculations & statistics. Offer services of pharmacokinetics calculations and statistics of bioanalytical data coming from preclinical and clinical studies. It uses the phoenix winnonlin® soft...
  • Polysaccharides analysis

    Product Polysaccharides analysis

    Kymos S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes polysaccharides analysis. Kymos have implemented and validated these challenging assays according to usp monograph and are ready to be used for drug product and drug substance. H...
  • Residue Depletion Studies & Bioequivalence

    Product Residue Depletion Studies & Bioequivalence

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes residue depletion studies & bioequivalence. 

    We validate methods and analyse sample for pharmacokinetics, residue-depletion studies and bioequivalence stu...
  • Stability Studies

    Product Stability Studies

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes stability studies. Kymos provide full service of ich and on-going stability programs for third parties. The services, at client's choice, can include: method tra...
  • Vaccine Potency Assays

    Product Vaccine Potency Assays

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes vaccine potency assays. Suports in the development of potency assay of vaccines for quality control in order to substitute "in vivo" testing. We are able to perf...
  • Bioanalysis of Small Molecules

    Product Bioanalysis of Small Molecules

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioanalysis of small molecules. Kymos offer bioanalytical method development and validation of innovative small molecules by mass spectrometry. It has the experience of being the selected partner for ...
  • Immunogenicity

    Product Immunogenicity

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes immunogenicity. Kymos have develops new bioanalytical methods for immunogenicity studies of proteins and peptides following ema and fda guidelines on immunogenicity of therapeutic proteins. Depending ...
  • Method Development, Validation and Transfer

    Product Method Development, Validation and Transfer

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes method development, validation and transfer. Kymos has comprehensive knowledge in the development and validation of analytical proprietary and non-proprietary method...
  • Bioequivalence Studies

    Product Bioequivalence Studies

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioequivalence studies. Kymos are experts in bioanalysis for bioequivalence studies in collaboration with the sponsor and/or the selected clinical phase center. It has a long list of validated bioanal...
  • Percutaneous Absorption

    Product Percutaneous Absorption

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes percutaneous absorption. Kymos shows their experience in studies of percutaneous absorption for topical semisolid drug products using vertical diffusion cells (o franz cells). Both in vitro release te...
  • Absorption studies of Dietary Suplements and Phytopharmaceuticals

    Product Absorption studies of Dietary Suplements and Phytopharmaceuticals

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes absorption studies of dietary suplements and phytopharmaceuticals. It performs the bioanalysis of active ingredients in biological samples coming from clinical studies of nutraceuticals, medical devic...

Kymos Pharma Services, S.L. resources (2)

  • News Kymos Acquires Germany’s Prolytic

    Kymos, a Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has bought German company Prolytic GmbH in order to strengthen its activity in the biologics and advanced therapies market. The company previously acquired Italian firm Pharmaprogress in 2016.
  • Brochure KYMOS: Adding Value to Biopharma

    KYMOS recently had the pleasure to lead a TV program series about the importance of outsourcing service providers like ourselves in the provision of medicines. Since the outbreak of COVID-19 the general public is paying much more attention to the biopharmaceutical industry and the challenges of conducting drug development, manufacturing, quality control and supply in the midst of a global pandemic. We invite you to watch this 2-minute English video and celebrate society's rising awareness of the key role played by the pharma and biotech sectors in our day-to-day lives.